These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 968783)

  • 1. [Influence of ornithine aspartate on the experimentally induced hyperammoniemia. Clinico-experimental study].
    Henglein-Ottermann D
    Ther Ggw; 1976 Sep; 115(9):1504-18. PubMed ID: 968783
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the therapy of liver diseases with ornithine aspartate].
    Melzer H; Weber D; Wotzka R
    Med Klin; 1969; 64(35):1541-4. PubMed ID: 5354488
    [No Abstract]   [Full Text] [Related]  

  • 3. [Further clinical experiences with ornithine aspartate in liver diseases].
    Wotzka R; Weber D
    Ther Ggw; 1972 Mar; 111(3):400-12. PubMed ID: 5024593
    [No Abstract]   [Full Text] [Related]  

  • 4. [Recent acquisitions on the pathogenesis of hyperammoniemia: clinico-experimental study on a new anti-ammonia drug].
    Furiosi P; Mercati U; Pasquini F
    Minerva Med; 1967 Feb; 58(15):553-63. PubMed ID: 6021622
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experiences with ornithine-aspartate in liver diseases].
    Aschke J
    Med Welt; 1969 Mar; 12():657-62. PubMed ID: 5767441
    [No Abstract]   [Full Text] [Related]  

  • 6. [Hyperammoniemia and its treatment].
    Szám I
    Orv Hetil; 1973 Oct; 114(43):2581-9. PubMed ID: 4585544
    [No Abstract]   [Full Text] [Related]  

  • 7. [Personal experiences in the treatment of internal diseases with ornithine aspartate].
    Perinović M; Robović Z; Grujić M; Ljubojević S
    Med Arh; 1969; 23(3):29-32. PubMed ID: 5200044
    [No Abstract]   [Full Text] [Related]  

  • 8. [Our clinical experience with ornithine aspartate].
    Szirmai E
    Minerva Med; 1971 Jun; 62(47):2376-82. PubMed ID: 5087700
    [No Abstract]   [Full Text] [Related]  

  • 9. [Modification of experimentally induced endogenous hyperammoniemia by amino acids in the rat].
    Hermann G
    Arzneimittelforschung; 1970 Mar; 20(3):377-9. PubMed ID: 5467512
    [No Abstract]   [Full Text] [Related]  

  • 10. [Therapy of hyperammoniemia].
    Nordmann R
    Dtsch Med Wochenschr; 1969 Jan; 94(5):230-1. PubMed ID: 5762228
    [No Abstract]   [Full Text] [Related]  

  • 11. [Protection of the liver and liver therapy with Hepamerz].
    Heynen U
    Z Allgemeinmed; 1970 Jan; 46(2):87-8. PubMed ID: 5439291
    [No Abstract]   [Full Text] [Related]  

  • 12. [Intravenous administration of ornithine aspartate to patients with hepatic diseases].
    Schäfer W
    Munch Med Wochenschr; 1968 Oct; 110(43):2521-5. PubMed ID: 5755238
    [No Abstract]   [Full Text] [Related]  

  • 13. [Clinical experiences in liver diseases (specially in patients with fatty liver due to alcoholism and food poisoning) under monotherapy with ornithine aspartate].
    Hunold W
    Z Allgemeinmed; 1973 Apr; 49(10):469-72. PubMed ID: 4580434
    [No Abstract]   [Full Text] [Related]  

  • 14. [Clinical study on the effects of L-ornithine-L-aspartate on liver dysfunction].
    Kosozu K
    Iryo; 1966 Apr; 20(4):339-46. PubMed ID: 5974192
    [No Abstract]   [Full Text] [Related]  

  • 15. Protection by ornithine-aspartate of the effects of physical exercise.
    Cutinelli L; Sorrentino L; Tramonti C; Salvatore F; Cedrangolo F
    Arzneimittelforschung; 1970 Aug; 20(8):1064-7. PubMed ID: 5536502
    [No Abstract]   [Full Text] [Related]  

  • 16. Experimental liver damage in potassium depletion, inhibited by L-ornithine-L-aspartate.
    Raab WP
    Arzneimittelforschung; 1971 Oct; 21(10):1620-1. PubMed ID: 5171899
    [No Abstract]   [Full Text] [Related]  

  • 17. [Study of the treatment of liver damage due to several causes in tuberculosis, using ornithine-aspartate].
    Seki S
    Iryo; 1966 Apr; 20(4):354-63. PubMed ID: 5974194
    [No Abstract]   [Full Text] [Related]  

  • 18. [Therapy of severe hyperammonemia].
    Leonhardt H; Bungert HJ
    Med Klin; 1972 Aug; 67(32):1052-6. PubMed ID: 5070916
    [No Abstract]   [Full Text] [Related]  

  • 19. Amino acids mixtures in prevention of acute ammonia intoxication in dogs.
    Grossi CE; Prytz B; Rousselot LM
    Arch Surg; 1967 Feb; 94(2):261-6. PubMed ID: 6016275
    [No Abstract]   [Full Text] [Related]  

  • 20. [Action of ornighine alpha-ketoglutarate on hyperammoniemia in the cirrhotic patient].
    Michel H; Ogé P; Bertrand L
    Presse Med (1893); 1971 Apr; 79(19):867-8. PubMed ID: 5576498
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.